|
Name: Quazepam
Type: Benzodiazepine
AKA: Doral
|
|
II. Natural Derivative
Synthetic substance, no natural derivative
 |
|
III. Chemical Profile (IUPAC name)
|
|
IV. History
Quazepam, a benzodiazepine, was developed in the 1970s. It is used for its sedative and anxiolytic effects and is studied for its potential therapeutic uses in treating anxiety and sleep disorders.
|
|
V. Legal Information
Quazepam, a benzodiazepine, is classified as a Schedule IV controlled substance in the US, allowing limited medical use. It is similarly regulated in many countries due to its potential for abuse and dependency. The UNODC emphasizes the need for balanced regulation to ensure safe medical use while preventing misuse. Trends indicate ongoing control measures to monitor and regulate benzodiazepines.
US Federal Schedule - IV
Schedule IV drugs, substances, or chemicals are defined as drugs with a low potential for abuse and low risk of dependence. Some examples of Schedule IV drugs are: Xanax, Soma, Darvon, Darvocet, Valium, Ativan, Talwin, Ambien, Tramadol.
Key US Federal Policies:
Controlled Substances Act. Public Law: Public Law 91-513 (text can be found on GovInfo) (https://www.dea.gov/drug-information/csa). Date enacted: October 27, 1970.
|
|
VI. Physical Effects
Quazepam is a benzodiazepine used for its sedative and anxiolytic effects. It acts as a downer, causing sedation and reduced anxiety. Short-term use is effective for managing anxiety and sleep disorders, but long-term use may lead to dependence and cognitive impairment. Overdose risks include severe sedation and respiratory depression. Safe use requires precise dosing and medical supervision. Recent research explores its efficacy and associated risks.  |
|
VII. Psychological Effects
Quazepam, a benzodiazepine, enhances GABA effects leading to sedation, anxiolysis, and muscle relaxation. Immediate effects include reduced anxiety, improved mood, and sedation. Long-term use can result in dependence, tolerance, and withdrawal symptoms. Chronic use is associated with cognitive impairment, depressive disorders, and increased anxiety. Recent studies indicate benzodiazepines can lead to structural changes in the brain.
 |
|
VIII. Culture
Quazepam is a benzodiazepine with anxiolytic and hypnotic properties, classifying it as a downer. Short-term use reduces anxiety and induces sleep, while long-term use can lead to dependence and withdrawal symptoms. Overdose risks include severe respiratory depression and potentially fatal outcomes. Safe dosages are medically prescribed, typically under 15 mg per day. Recent research highlights its efficacy in anxiety and insomnia management but warns of addiction risks. Physical effects include drowsiness, dizziness, and impaired coordination.
 |